Quick View
| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥183.0B | ¥170.6B | +7.2% |
| Operating Income | ¥25.3B | ¥34.4B | −26.3% |
| Ordinary Income | ¥24.3B | ¥34.3B | −29.0% |
| Net Income | ¥16.9B | ¥23.8B | −25.7% |
| ROE | 8.3% | 12.8% | - |
Executive Summary
FY2026 Q3 results showed revenue of 183.0B yen (YoY +7.2%), while operating income declined significantly to 25.3B yen (YoY -26.3%). Ordinary income decreased to 24.3B yen (YoY -29.0%) and net income fell to 16.9B yen (YoY -29.1%). Despite maintaining a high gross margin of 77.6%, the company experienced substantial profit compression due to increased selling, general, and administrative expenses. Operating cash flow turned negative at -0.5B yen, raising concerns about earnings quality and cash conversion capability. The balance sheet remains solid with total assets of 258.3B yen and equity of 202.6B yen, though short-term borrowings increased substantially by 20.0B yen to 36.0B yen. Inventory rose 30.2% to 18.4B yen, resulting in elevated inventory turnover days of 164. The company maintains its full-year forecast of 260.0B yen revenue (YoY +14.2%) but expects operating income of 3.8B yen (YoY -8.0%), indicating continued margin pressure.
Key Metrics
[Profitability] ROE of 8.3% reflects net profit margin of 9.2%, asset turnover of 0.708, and financial leverage of 1.28x in DuPont decomposition. Operating margin declined to 13.8%, down from prior year levels, while gross margin remained strong at 77.6%. The margin compression stems primarily from increased SG&A expenses that outpaced revenue growth of 7.2%. [Cash Quality] Cash and deposits stood at 96.4B yen, providing coverage of 2.68x against short-term borrowings of 36.0B yen. Operating cash flow of -0.5B yen produced an OCF-to-net-income ratio of -0.03x, indicating weak cash conversion and earnings quality concerns. Free cash flow was negative at -13.3B yen, driven by investing activities of -8.5B yen and negative operating cash flow. [Investment Efficiency] Asset turnover of 0.708 reflects adequate capital utilization. Inventory turnover deteriorated to 164 days, up substantially from prior periods, suggesting working capital inefficiency. Receivables turnover remained moderate. Capital expenditure of 2.2B yen exceeded depreciation by 1.68x, indicating ongoing growth investment. [Financial Health] Equity ratio of 78.4% demonstrates strong capital adequacy. Current ratio of 408.6% and quick ratio of 374.6% indicate robust short-term liquidity. Debt-to-equity ratio of 0.18 and debt-to-EBITDA of 1.35x reflect conservative leverage. However, short-term debt concentration reached 100% of interest-bearing debt, creating refinancing considerations despite ample cash reserves.
Cash Flow Analysis
Cash and deposits increased 47.4B yen YoY to 96.4B yen, supported by short-term borrowing expansion of 20.0B yen. Operating cash flow turned negative at -0.5B yen despite net income of 16.9B yen, reflecting working capital build including inventory increase of 3.3B yen and other working capital movements. The negative cash conversion ratio of -0.03x indicates earnings are not translating into cash generation. Investing cash flow of -8.5B yen consisted primarily of capital expenditures of 2.2B yen and investments in securities and subsidiaries totaling approximately 6.3B yen. Financing activities reflected dividend payments of approximately 14.7B yen offset by the 20.0B yen increase in short-term borrowings, resulting in net positive financing cash flow. Free cash flow of -13.3B yen indicates the company required external funding to support operations, investments, and dividends. The substantial cash position of 96.4B yen provides 2.68x coverage of short-term liabilities, maintaining adequate liquidity buffer despite negative operating cash flow. Working capital stood at 167.1B yen but efficiency declined due to inventory accumulation, with days inventory outstanding reaching 164 days.
Earnings Quality
Ordinary income of 24.3B yen compared to operating income of 25.3B yen shows a non-operating net loss of approximately 1.0B yen. Non-operating items included financial expenses and other costs that slightly offset operating performance. The non-operating impact represents 0.5% of revenue, a relatively minor contribution. Interest expenses of 0.2B yen resulted in an interest coverage ratio of 117x, indicating limited financial burden. However, operating cash flow of -0.5B yen falling below net income of 16.9B yen raises significant earnings quality concerns. The negative OCF-to-net-income ratio of -0.03x suggests substantial accruals or working capital deterioration undermining reported profits. The 30.2% increase in inventory to 18.4B yen and elevated inventory days of 164 indicate potential overstatement of earnings through inventory buildup or inadequate provisions. With operating cash flow unable to support reported earnings, the sustainability of profit levels warrants close monitoring until cash conversion improves.
Risk Factors
-
Working Capital Efficiency Risk: Inventory increased 30.2% to 18.4B yen with inventory turnover extending to 164 days, significantly above industry norms. This accumulation ties up capital and creates exposure to obsolescence, price markdowns, and demand fluctuations. The inability to convert inventory to cash constrains liquidity and operating cash flow generation.
-
Operating Leverage and Margin Pressure: Despite 7.2% revenue growth, operating income fell 26.3% due to SG&A expense growth outpacing sales. Operating margin compression from prior year levels to 13.8% indicates deteriorating cost control. If revenue growth slows while fixed costs remain elevated, profitability could decline further.
-
Dividend Sustainability Risk: The calculated dividend payout ratio of 91.1% combined with negative free cash flow of -13.3B yen raises concerns about dividend coverage. Current dividend policy of 39.0 yen per share requires cash deployment exceeding earnings generation, necessitating either improved cash flow or potential dividend adjustment to maintain financial flexibility.
Industry Benchmark (Reference - Proprietary Data)
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE 8.3% aligns with industry median of 8.2% (2025-Q3, IT & Telecom sector). The company's net profit margin of 9.2% exceeds the industry median of 5.6%, ranking in the upper half of peers and reflecting strong pricing power or value-added services. Operating margin of 13.8% also surpasses the industry median of 8.0%, indicating superior operational efficiency at the gross profit level despite recent SG&A pressure. Financial Health: Equity ratio of 78.4% substantially exceeds the industry median of 59.5%, positioning the company in the top quartile for capital strength and financial stability. Current ratio of 408.6% far exceeds the industry median of 2.13x, demonstrating exceptional liquidity management. Efficiency: Asset turnover of 0.708 compares favorably to the industry median of 0.68, indicating slightly better capital utilization. However, inventory turnover days of 164 significantly exceed the industry median of 13.17 days, ranking among the weakest in the sector and highlighting material working capital inefficiency. Revenue growth of 7.2% trails the industry median of 10.5%, suggesting slower top-line momentum relative to peers. The company's Rule of 40 metric (revenue growth plus operating margin) of approximately 21% falls below the industry median of 20% but remains within acceptable range given the margin profile. ※ Industry: IT & Telecom (99 companies), Comparison: FY2025-Q3, Source: Proprietary analysis
Key Takeaways from Earnings
-
Margin Preservation Challenge Under Revenue Growth: The company achieved 7.2% revenue growth while maintaining an exceptionally high gross margin of 77.6%, indicating strong product or service differentiation. However, the 26.3% decline in operating income reveals that SG&A expense growth outpaced sales expansion, compressing operating margin to 13.8%. This pattern suggests either growth investment spending (sales personnel, marketing, R&D) or operational inefficiency. Management's ability to leverage fixed costs as revenue scales toward the full-year target of 260.0B yen will be critical. The full-year operating income forecast of 3.8B yen implies sequential improvement from Q3 levels is expected, requiring either revenue acceleration or expense discipline in Q4.
-
Working Capital Management Requires Urgent Attention: The 30.2% increase in inventory to 18.4B yen and inventory days of 164 significantly exceed industry norms of 13 days, creating both operational and financial risks. This inventory buildup, combined with negative operating cash flow of -0.5B yen, indicates either demand forecasting challenges, production inefficiencies, or strategic stockpiling. The company's OCF-to-net-income ratio of -0.03x ranks poorly against the industry median cash conversion ratio of 1.40x, suggesting earnings quality deterioration. Reducing inventory levels and improving receivables collection would release substantial working capital, enabling positive free cash flow generation without external funding.
-
Capital Allocation Under Scrutiny Despite Strong Balance Sheet: The company maintains robust financial health with 78.4% equity ratio and 96.4B yen cash position, well above industry medians. However, the combination of 91.1% dividend payout ratio, negative FCF of -13.3B yen, and 8.5B yen in ongoing investments creates tension between shareholder returns and growth funding. The 20.0B yen increase in short-term borrowings effectively financed dividends and investments that operating cash flow could not support. While current liquidity remains ample at 2.68x short-term debt coverage, sustaining this capital allocation without improved cash generation would gradually erode financial flexibility. Management faces a strategic choice between maintaining high dividends, funding growth investments, or prioritizing operational cash flow improvement through working capital optimization.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was mixed: revenue expanded, but a sharp gross-margin reset and negative operating cash flow drove a material deterioration in earnings quality. Cumulative Q3 revenue rose 7.2% year on year to ¥18.30bn. Operating income fell 26.3% to ¥2.53bn, ordinary income declined 29.0% to ¥2.43bn, and net income attributable to owners decreased 25.7% to ¥1.68bn. The operating margin contracted 640bp year on year to 13.8% from 20.2%. The gross margin fell 680bp to 77.6% from 84.4%, indicating that the principal earnings pressure arose below gross profit rather than solely from overhead. Net margin compressed 410bp to 9.2% from 13.3%. SG&A increased 6.4% to ¥11.66bn, broadly tracking revenue growth, but the cost of sales increase of 54.2% materially exceeded revenue growth and eroded operating leverage. EBITDA was ¥2.66bn and the EBITDA margin was 14.6%. Under JGAAP, goodwill amortization was ¥0.84bn, or 3.1% of pre-goodwill-amortization EBITDA, representing a limited rather than material accounting distortion to earnings. Annualized ROE was 11.1%, which remains in a good 10-15% range, supported by a 9.2% net margin, 0.945x asset turnover, and conservative 1.28x financial leverage. Cash-flow quality was weak, with operating cash flow of negative ¥0.47bn against net income of ¥1.68bn and OCF/net income of negative 0.28x. Inventory increased ¥4.27bn year on year and operating cash flow also absorbed cash through tax payments and other working-capital movements. The balance sheet remains highly liquid, with cash of ¥9.63bn, a 408.6% current ratio, and cash equal to 2.68x short-term debt. However, all ¥3.60bn of interest-bearing debt is short term, and the ¥2.00bn year-on-year debt increase funded cash needs during a period of negative operating and investing cash flow. Q3 revenue progress was 70.4% of the ¥26.0bn full-year forecast, below the standard 75% Q3 run rate, while operating-income progress was 66.7%. Achieving guidance requires a Q4 operating margin of approximately 16.4%, above the Q3 cumulative 13.8% margin, making gross-margin recovery and working-capital normalization the central execution issues.
Profitability Analysis
The annualized DuPont ROE of 11.1% is decomposed into a 9.2% net profit margin, 0.945x asset turnover, and 1.28x financial leverage. The principal negative change was margin compression rather than leverage: gross margin declined 680bp, operating margin declined 640bp, and net margin declined 410bp year on year. Revenue growth of 7.2% was insufficient to offset the 54.2% increase in cost of sales, which reduced gross profit by 1.4% to ¥14.19bn despite higher sales. SG&A grew 6.4%, slightly below revenue growth, so fixed-cost control was not the primary source of the profit decline; rather, the company experienced adverse gross-profit conversion. The 13.8% EBIT margin remains within the stated 8-15% good range, but is materially below the prior-year level and below the >15% excellent threshold. The five-factor decomposition shows a 0.695 tax burden, a 0.956 interest burden, and a 13.8% EBIT margin. The interest burden remains healthy because interest expense was only ¥0.22bn and interest coverage was 117.0x, so financing costs did not drive the decline in net income. The effective tax rate was 30.4%, broadly consistent with the tax-burden result. Ordinary income was ¥2.43bn, only ¥0.10bn below operating income, indicating limited dependence on non-operating income. Non-operating income was only ¥0.46bn, or 0.3% of revenue, while foreign-exchange losses were ¥0.34bn. An extraordinary loss on disposal of fixed assets of ¥0.12bn was immaterial relative to profit before tax. EBITDA was ¥2.66bn, and EBITDA before JGAAP goodwill amortization was ¥2.75bn. Goodwill amortization was only 3.1% of pre-goodwill-amortization EBITDA, below the level at which JGAAP accounting would materially impair comparability with IFRS reporters. Margin recovery appears necessary to meet the full-year operating-income target, so the sustainability of ROE depends primarily on restoring gross profitability rather than increasing financial leverage.
Growth Assessment
Revenue growth of 7.2% demonstrates continued top-line expansion, but the lower conversion of sales into gross profit weakens the quality of that growth. The cost of sales increase materially outpaced sales growth, resulting in gross profit declining 1.4% year on year despite the higher revenue base. Operating income, ordinary income, and net income all declined by more than 25%, showing negative operating leverage at the current cost mix. The full-year forecast calls for revenue of ¥26.0bn, up 14.2% year on year, operating income of ¥3.80bn, down 8.0%, and ordinary income of ¥3.70bn, down 9.7%. Revenue progress is 70.4% at Q3 versus a standard 75% run rate, a 4.6 percentage-point shortfall that is not by itself severe but requires a stronger final quarter. Operating-income progress is 66.7%, 8.3 percentage points below the standard Q3 pace. Net-income progress is 61.2% of the ¥2.75bn forecast, 13.8 percentage points below the standard pace and therefore notably back-end loaded. Meeting the forecast requires Q4 revenue of ¥7.70bn, operating income of ¥1.27bn, and net income attributable to owners of ¥1.07bn. The implied Q4 operating margin is approximately 16.4%, 260bp above the Q3 cumulative margin, requiring a meaningful improvement in gross-margin conversion. The relatively small gap between operating and ordinary income suggests that forecast delivery is predominantly an operational execution issue rather than a question of financial income. Investment in property, plant and equipment was ¥2.21bn, with capex/depreciation of 1.68x, indicating continued investment rather than underinvestment. The key growth question is whether higher inventory and associated working-capital deployment can be converted into revenue and gross profit without further margin dilution.
Financial Health
Financial health is strong on reported liquidity and moderate on leverage. Current assets of ¥22.13bn exceeded current liabilities of ¥5.42bn, producing a 408.6% current ratio and a 374.6% quick ratio. Working capital was ¥16.71bn, and cash and deposits were ¥9.63bn, equivalent to 37.3% of total assets. Total liabilities represented only 21.6% of total assets, while total equity was ¥20.26bn. Debt-to-equity was a conservative 0.28x, debt-to-capital was 15.1%, and debt/EBITDA was 1.35x, all comfortably within conservative credit benchmarks. Interest coverage of 117.0x and EBITDA interest coverage of 123.1x indicate ample capacity to service current interest obligations. Short-term loans increased ¥2.00bn year on year, or 124.8%, to ¥3.60bn. The short-term debt ratio is 100%, which is a refinancing-risk flag because all borrowings mature within one year rather than being term matched to longer-lived assets. This maturity concentration is mitigated substantially by cash equal to 2.68x short-term debt and by current assets exceeding current liabilities by ¥16.71bn. Inventories increased ¥4.27bn, or 30.2%, to ¥18.42bn and represented 7.1% of total assets. Investment securities increased ¥2.52bn, or 44.9%, to ¥8.15bn, increasing the amount of capital exposed to market-value and investment-performance movements. Goodwill was ¥5.74bn, equal to only 2.8% of equity and 0.22x EBITDA, so the balance sheet is not materially dependent on acquired goodwill values. Goodwill and other intangible assets together represented only 4.5% of assets, limiting impairment concentration risk.
Notable B/S Changes
Short-term loans: +¥2.00bn (+124.8%) to ¥3.60bn - financing increased materially while operating and investing cash flows were negative; all debt is short term, although cash covers it 2.68x. Investment securities: +¥2.52bn (+44.9%) to ¥8.15bn - larger allocation to investment assets increases exposure to valuation and investment-performance movements. Inventories: +¥4.27bn (+30.2%) to ¥18.42bn - consistent with 123 inventory days and weak operating cash conversion; turnover and cash realization require close monitoring.
Cash Flow Quality
Cash-flow quality is the principal financial concern in Q3. Operating cash flow was negative ¥0.47bn despite net income attributable to owners of ¥1.68bn, resulting in an OCF/net income ratio of negative 0.28x, well below the 0.8x concern threshold. Cash conversion, measured as OCF/EBITDA, was negative 0.18x, also well below the 0.7x warning threshold. The 8.3% accruals ratio is not above the 10% high-concern benchmark, but the negative operating cash flow shows that earnings have not converted into cash during the period. Inventory increased ¥4.27bn, directly consuming operating cash and underpinning the high-inventory-days alert of 123 days. Inventory days exceed both the 90-day and 60-day warning thresholds cited in the quality alerts, increasing the risk of slower turnover, valuation pressure, or a need for discounting if demand does not convert as expected. The cash conversion cycle was 121 days, marginally above the 120-day warning threshold; this signals that cash is tied up in the operating cycle for an extended period. Trade receivables decreased ¥2.30bn, which was a cash-release offset, so receivables are not the driver of the weak cash conversion. Other assets increased by ¥3.08bn and other liabilities declined by ¥8.77bn, adding to cash absorption. Income taxes paid were ¥11.17bn, exceeding the ¥6.37bn operating-cash-flow subtotal before taxes and contributing to the negative reported operating cash flow. Capital expenditure was ¥2.21bn, above depreciation and amortization of ¥1.31bn, consistent with growth investment. Conventional operating cash flow less capex was negative ¥6.95bn, while reported free cash flow including investing cash flow was negative ¥13.26bn. Investing cash flow was negative ¥8.51bn, including ¥3.41bn of investment-security purchases and ¥4.74bn of lease-deposit payments. Financing cash flow of ¥17.53bn, principally supported by a ¥19.96bn increase in short-term loans, funded the aggregate operating and investing cash deficit and produced a ¥5.49bn increase in cash. This financing dependence should recede if inventory and other working capital normalize in the final quarter.
Dividend Sustainability
The disclosed interim dividend was ¥38.0 per share. Based on the full-year forecast DPS of ¥77.0 and forecast EPS of ¥143.74, the prospective dividend payout ratio is approximately 53.6%, within the stated sub-60% sustainable benchmark. The Q3 calculated payout ratio of 44.9% is also moderate relative to cumulative net income. However, cash coverage was weak in the reported period because operating cash flow was negative ¥0.47bn and reported free cash flow was negative ¥13.26bn. Cash dividends paid were ¥14.72bn, substantially exceeding operating cash generation during Q3. The resulting FCF coverage of negative 1.75x means internally generated free cash flow did not cover distributions in the period. The balance sheet provides material support, with ¥9.63bn of cash, a 408.6% current ratio, and low debt-to-capital of 15.1%. Therefore, the dividend burden is sustainable on an earnings-payout and liquidity basis at present, but sustained negative operating cash flow would weaken that assessment. Dividend durability depends on converting inventory and other working-capital investment into cash while delivering the forecast Q4 earnings recovery.
Risk Assessment
Business risks include Margin-execution risk: gross margin fell 680bp to 77.6% as cost of sales rose 54.2% against 7.2% revenue growth. The required Q4 operating margin of approximately 16.4% makes restoration of project profitability and cost conversion a high-impact issue., Working-capital and inventory risk: inventories rose 30.2% to ¥18.42bn and inventory days reached 123 days. This is materially above both cited warning thresholds and can lead to slower cash realization or margin pressure if turnover weakens., Cash-conversion-cycle risk: the 121-day cash conversion cycle exceeds the 120-day alert threshold. Extended operating-cycle duration can require more external financing even when reported earnings remain positive., Consulting and advisory demand risk: revenue growth and final-quarter margin recovery depend on client decision-making, transaction activity, and successful delivery of higher-value projects; a weaker corporate investment or business-succession environment could delay revenue recognition and reduce utilization..
Financial risks include Earnings-quality risk: OCF/net income was negative 0.28x and OCF/EBITDA was negative 0.18x. The divergence indicates that Q3 accounting earnings did not translate into cash and raises the importance of a Q4 working-capital reversal., Refinancing-risk flag: 100% of ¥3.60bn interest-bearing debt is short term. Although cash covers this debt 2.68x and interest coverage is strong, the maturity concentration increases dependence on continued access to bank liquidity., Financing-dependence risk: a ¥19.96bn increase in short-term loans was the main source of positive financing cash flow while operating and investing cash flows were both negative., Investment-security exposure: investment securities increased 44.9% to ¥8.15bn, creating greater sensitivity to investment performance and market valuation changes..
Key concerns include The quality alerts on negative OCF/net income and negative cash conversion are confirmed by negative ¥0.47bn operating cash flow despite ¥1.68bn net income., The duplicate high-inventory alerts are material rather than merely technical: 123 inventory days are above both the 90-day and 60-day reference thresholds, and inventory growth absorbed cash., Forecast attainment is back-end loaded, particularly for net income, where Q3 progress of 61.2% is 13.8 percentage points below the standard 75% Q3 pace., Liquidity is strong and mitigates the near-term debt maturity issue, but improvement in operating cash flow is necessary to reduce reliance on short-term debt funding..
Investment Implications
Key takeaways include Top-line growth remained positive at 7.2%, but profit conversion deteriorated substantially, with operating income down 26.3% and the operating margin down 640bp., Annualized ROE of 11.1% remains respectable and is supported by profitability and asset turnover rather than aggressive leverage., Balance-sheet liquidity is substantial, with ¥9.63bn cash, a 408.6% current ratio, and cash exceeding short-term debt by 2.68x., Negative operating cash flow and a 123-day inventory profile are the critical near-term quality issues., Full-year guidance requires an implied Q4 operating-margin recovery to about 16.4%, making gross-margin normalization the most important earnings catalyst..
Metrics to watch include Gross margin and operating margin recovery versus the Q3 levels of 77.6% and 13.8%, Operating cash flow, OCF/net income, and OCF/EBITDA conversion, Inventory balance and inventory days relative to the current 123 days, Cash conversion cycle relative to the current 121 days, Short-term loan balance, refinancing terms, and cash-to-short-term-debt coverage, Q4 revenue, operating-income, and net-income delivery versus the ¥26.0bn, ¥3.80bn, and ¥2.75bn full-year forecasts.
Regarding relative positioning, The company combines good annualized ROE, strong liquidity, low balance-sheet goodwill exposure, and conservative headline leverage with weaker current-period earnings conversion than its reported profit metrics imply. Its financial profile is therefore more resilient than the negative cash flow alone suggests, but relative performance will be determined by whether it can reverse inventory-led working-capital absorption and restore gross margins without adding further short-term funding.